Delivery Order SPE2DR25D2206-SPE2DR26F0BHF
- Not listed
- The Defense Logistics Agency issued a $7,233.16 delivery order to Amerisourcebergen Drug Corp on April 20, 2026, for Revlimid 25 mg capsules (21-count). Place of performance is Conshohocken, PA. The order has a firm fixed-price structure with an ultimate completion date of May 11, 2026. No set-aside was used. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor supplying brand-name and generic medications, specialty pharmaceuticals, and...
- The Defense Logistics Agency issued a $7,439.33 delivery order to Amerisourcebergen Drug Corp on April 20, 2026, for Revlimid 15 mg capsules (21-count). Place of performance is Conshohocken, PA. Ultimate completion date is May 11, 2026. The order carries a firm fixed-price structure with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and holds a single-award indefinite delivery contract with DLA Troop Support Medical (SPE2DX) valued at $4.999 million through...
- The Defense Logistics Agency awarded a $20,920.36 delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Revlimid 15 mg capsules (21-count units). This is a firm fixed price, non-set-aside contract with performance completion scheduled for December 10, 2025, and fulfillment occurring at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $7,233.16 to AmerisourceBergen Drug Corp for the supply of Revlimid 25 mg capsules (21-count) on January 23, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is scheduled for completion by February 13, 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a...
- The Defense Logistics Agency awarded a $14,122.63 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 28 capsules of the pharmaceutical Revlimid 10 mg. The order is being fulfilled under an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will deliver the Revlimid capsules to a facility in Conshohocken, Pennsylvania by September 12, 2023 to support DLA and DoD medical readiness...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corp a delivery order valued at $19,176.36 on January 14, 2026, for the supply of Revlimid 10 mg capsules (28-count packages). This firm fixed-price, non-set-aside contract is scheduled for completion by February 5, 2026, with performance taking place at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under Amerisourcebergen's parent company Cencora, Inc.'s larger Indefinite...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at fourteen thousand two hundred thirty-five dollars and fifty-six cents ($14,235.56) to Amerisourcebergen Drug Corporation for the provision of five milligram Revlimid capsules. Under the terms of the contract, Amerisourcebergen will deliver twenty-eight (28) capsules to the agency's location in Conshohocken, Pennsylvania between July 18 and August 8, 2023. As the prime contractor, Amerisourcebergen will be...
- The Defense Logistics Agency awarded a delivery order valued at approximately $51.7K to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (28-count units). This firm fixed-price delivery order, awarded on September 3, 2025, with an ultimate completion date of September 24, 2025, represents a non-competitive procurement executed under an existing contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred twenty-seven thousand four hundred forty-two dollars and forty-six cents ($127,442.46) to Amerisourcebergen Drug Corporation for the provision of twenty-eight (28) capsules of the pharmaceutical Revlimid (lenalidomide) per package. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period spanning September 5 through September 26, 2023. As a major provider of...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately ninety-five thousand dollars to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide one hundred capsules of the pharmaceutical Revlimid to support the Defense Logistics Agency's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three week period concluding in early August. As the prime contractor,...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F0BHFDelivery Order
The Defense Logistics Agency issued a $31,269.57 delivery order to Amerisourcebergen Drug Corp on April 20, 2026, for pharmaceutical supply (Revlimid 2.5 mg capsules, 28-count). Place of performance is Conshohocken, PA. The order has a firm fixed-price structure with an ultimate completion date of May 11, 2026. No set-aside was used. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor and medical supplier to the Department of Defense and federal healthcare systems. The company holds a single-award indefinite delivery contract with the Defense Logistics Agency valued at $4.999 million through December 2036, supporting the Pharmaceutical Prime Vendor Global Program Generation V for worldwide military healthcare supply.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.3k | 4/19/26 |